tirzepatide dfw Compound Tirzepatide (Mounjaro) In Sherman Oaks

Although the amount of cyanide released through cyanocobalamin injections is, clinically-speaking, completely irrelevant

The FDA has flagged safety risks for several compounded peptides, including immunogenicity and impurity concerns

A recent phase 2 trial testing doses of up to 16 mg/week suggests that, while higher doses yield further improvements in blood glucose and body weight, there is no clinical justification for exceeding the approved dose of 2 mg/week due to increased frequency of AEs

Purity: Free from harmful fillers, colours or artificial additives

Mounjaro is FDA-approved for managing type 2 diabetes, but it is also commonly prescribed for weight loss in qualified patients